Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies held a board meeting on 31st March 2025 and approved two key changes. Ms. Pushpa Joshi was appointed as an Additional Non-Executive Independent Director, subject to shareholder approval. Ms. Aesha Harsh Shah resigned as Independent Director citing personal reasons, effective the same day. The company confirmed there are no other material reasons behind her resignation. Following these changes, the Audit Committee and Nomination and Remuneration Committee were reconstituted to include the new director.
This is a routine board-level reshuffle with no material impact on business or shareholders. The independent director seat remains filled, maintaining board continuity and compliance with listing requirements.